Accord Healthcare Ltd, Ipratropium Bromide 500 microgram/2ml nebuliser solution recall

Class 3 medicines recall: The MHRA has published a Class 3 medicines recall for Ipratropium Bromide 500 microgram/2ml nebuliser solution.

Published: 23 October 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Ipratropium Bromide 500 microgram/2ml nebuliser solution. Accord Healthcare Ltd is recalling a batch after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. The incorrectly labelled ampoules are the same product and contain the same active ingredient but have Korean language labels and different batch details.

Pharmacists are advised to stop supplying the batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Further information, advice and details of the affected batch can be found on the MHRA website.